BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 16047204)

  • 1. Colony-stimulating factors in the management of neutropenia and its complications.
    Heuser M; Ganser A
    Ann Hematol; 2005 Oct; 84(11):697-708. PubMed ID: 16047204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of colony-stimulating factors for chemotherapy-associated neutropenia: review of current guidelines.
    Heuser M; Ganser A; Bokemeyer C; ; ;
    Semin Hematol; 2007 Jul; 44(3):148-56. PubMed ID: 17631179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost considerations in therapy with myeloid growth factors.
    Glaspy JA; Jakway J
    Am J Hosp Pharm; 1993 Jul; 50(7 Suppl 3):S19-26. PubMed ID: 7689789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colony-stimulating factors: clinical applications.
    Blackwell S; Crawford J
    Pharmacotherapy; 1992; 12(2 Pt 2):20S-31S. PubMed ID: 1598311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current status of the clinical application of hematopoietic growth factors in oncology].
    Karthaus M; Ganser A
    Ther Umsch; 1996 Nov; 53(11):863-73. PubMed ID: 8984692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical use of colony stimulating factors.
    Moore MA
    Annu Rev Immunol; 1991; 9():159-91. PubMed ID: 1910675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines.
    J Clin Oncol; 1994 Nov; 12(11):2471-508. PubMed ID: 7964965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical applications of recombinant human colony-stimulating factors.
    Klingemann HG
    CMAJ; 1989 Jan; 140(2):137-42. PubMed ID: 2642725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomized controlled trials.
    Clark OA; Lyman GH; Castro AA; Clark LG; Djulbegovic B
    J Clin Oncol; 2005 Jun; 23(18):4198-214. PubMed ID: 15961767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economics of the colony-stimulating factors in the prevention and treatment of febrile neutropenia.
    Lyman GH; Kuderer NM
    Crit Rev Oncol Hematol; 2004 May; 50(2):129-46. PubMed ID: 15157662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.
    Bhana N
    Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte colony-stimulating factor use in patients with chemotherapy-induced neutropenia: clinical and economic benefits.
    Rader M
    Oncology (Williston Park); 2006 Apr; 20(5 Suppl 4):16-21. PubMed ID: 16736984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cost analysis of hematopoietic colony-stimulating factors.
    Lyman GH; Balducci L
    Oncology (Williston Park); 1995 Nov; 9(11 Suppl):85-91. PubMed ID: 8608061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic growth factors in the treatment of acquired bone marrow failure states.
    Marsh JC; Ganser A; Stadler M
    Semin Hematol; 2007 Jul; 44(3):138-47. PubMed ID: 17631178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical usefulness of various CSFs].
    Takaku F
    Tanpakushitsu Kakusan Koso; 1991 May; 36(7):1466-72. PubMed ID: 1871369
    [No Abstract]   [Full Text] [Related]  

  • 16. [GM-CSF: its use in onco-hematologic diseases].
    Visani G; Tosi P; Benfenati D; Colombini R; Cenacchi AR; Gamberi B; Lemoli RM; Tura S
    Haematologica; 1989 Oct; 74(5 Suppl):501-10. PubMed ID: 2512232
    [No Abstract]   [Full Text] [Related]  

  • 17. [Colony stimulating factor].
    Takaku F
    Gan To Kagaku Ryoho; 1989 Nov; 16(11):3550-3. PubMed ID: 2817907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The resurgence of granulocyte transfusions.
    Harris DJ
    J Infus Nurs; 2009; 32(6):323-9. PubMed ID: 19918141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal use of granulocyte-colony-stimulating factor in patients with cancer who are at risk for chemotherapy-induced neutropenia.
    Cappozzo C
    Oncol Nurs Forum; 2004 May; 31(3):569-76. PubMed ID: 15146222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical applications of colony-stimulating factors.
    Vadhan-Raj S
    Oncol Nurs Forum; 1989; 16(6 Suppl):21-6. PubMed ID: 2687811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.